HCPCS Level II code S9002 identifies an intra-vaginal motion sensor system used to provide biofeedback for pelvic floor muscle rehabilitation. This code captures a device-driven therapy adjunct that supports conservative management of pelvic floor dysfunction, a condition with substantial prevalence and functional impact across adult populations. Nationally, clarity around device coding affects device access, coverage determinations, and care pathways for urinary incontinence and pelvic floor disorders.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and billing practices for biofeedback devices vary across these payers, influencing patient cost-sharing and where services are delivered.

Readers will find a concise overview of the code’s clinical role, typical sites of service, and the service type. The publication summarizes common modifiers and payer considerations, highlights where data is available or missing, and outlines the clinical context for use of an intra-vaginal motion sensor system. The material is intended to inform billing staff, clinicians, and policy analysts about coding implications, payer coverage patterns, and the operational setting for deploying this biofeedback device.